UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form
For the quarterly period ended
OR
For the transition period from ________________________to _________________________
Commission file number
(Exact name of Registrant as Specified in Its Charter)
| ||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
|
|
(
(Registrant’s Telephone Number, Including Area Code)
(Former Address, if Changed Since Last Report)
Title of each class |
| Trading Symbol |
| Name of each exchange on which registered |
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past ninety (90) days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act.
Large accelerated filer ◻ | Non-accelerated filer ◻ | Smaller reporting company | Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
Number of Shares of the only class of Common Stock outstanding:
ALLIED MOTION TECHNOLOGIES INC.
INDEX
PART I. FINANCIAL INFORMATION | Page No. | |||
Item 1. | Financial Statements |
| ||
1 | ||||
Condensed Consolidated Statements of Income and Comprehensive Income – Unaudited | 2 | |||
Condensed Consolidated Statements of Stockholders’ Equity – Unaudited | 3 | |||
4 | ||||
Notes to Condensed Consolidated Financial Statements - Unaudited | 5 | |||
Management's Discussion and Analysis of Financial Condition and Results of Operations | 18 | |||
24 | ||||
25 | ||||
26 | ||||
26 | ||||
26 | ||||
26 | ||||
26 | ||||
ALLIED MOTION TECHNOLOGIES INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(Unaudited)
March 31, | December 31, | |||||
| 2022 |
| 2021 | |||
Assets | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ | | $ | | ||
Trade receivables, net of provision for credit losses of $ | | | ||||
Inventories |
| |
| | ||
Prepaid expenses and other assets |
| |
| | ||
Total current assets |
| |
| | ||
Property, plant and equipment, net |
| |
| | ||
Deferred income taxes |
| |
| | ||
Intangible assets, net |
| |
| | ||
Goodwill |
| |
| | ||
Operating lease assets | | | ||||
Other long-term assets |
| |
| | ||
Total Assets | $ | | $ | | ||
Liabilities and Stockholders’ Equity | ||||||
Current liabilities: | ||||||
Accounts payable | $ | | $ | | ||
Accrued liabilities |
| |
| | ||
Total current liabilities |
| |
| | ||
Long-term debt |
| |
| | ||
Deferred income taxes |
| |
| | ||
Pension and post-retirement obligations |
| |
| | ||
Operating lease liabilities | | | ||||
Other long-term liabilities | | | ||||
Total liabilities |
| |
| | ||
Stockholders’ Equity: | ||||||
Common stock, |
| |
| | ||
Preferred stock, par value $ |
|
| ||||
Retained earnings |
| |
| | ||
Accumulated other comprehensive loss |
| ( |
| ( | ||
Total stockholders’ equity |
| |
| | ||
Total Liabilities and Stockholders’ Equity | $ | | $ | | ||
See accompanying notes to condensed consolidated financial statements.
1
ALLIED MOTION TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(In thousands, except per share data)
(Unaudited)
For the three months ended | ||||||
March 31, | ||||||
| 2022 |
| 2021 | |||
Revenues | $ | | $ | | ||
Cost of goods sold |
| |
| | ||
Gross profit |
| |
| | ||
Operating costs and expenses: | ||||||
Selling |
| |
| | ||
General and administrative |
| |
| | ||
Engineering and development |
| |
| | ||
Business development |
| |
| | ||
Amortization of intangible assets |
| |
| | ||
Total operating costs and expenses |
| |
| | ||
Operating income |
| |
| | ||
Other expense, net: | ||||||
Interest expense |
| |
| | ||
Other expense (income), net |
| |
| ( | ||
Total other expense, net |
| |
| | ||
Income before income taxes |
| |
| | ||
Income tax (provision) benefit |
| ( |
| | ||
Net income | $ | | $ | | ||
Basic earnings per share: | ||||||
Earnings per share | $ | | $ | | ||
Basic weighted average common shares |
| |
| | ||
Diluted earnings per share: | ||||||
Earnings per share | $ | | $ | | ||
Diluted weighted average common shares |
| |
| | ||
Net income | $ | | $ | | ||
Other comprehensive income: | ||||||
Foreign currency translation adjustment | ( | ( | ||||
Gain on derivatives | | | ||||
Comprehensive income | $ | | $ | | ||
See accompanying notes to condensed consolidated financial statements.
2
ALLIED MOTION TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In thousands, except per share data)
(Unaudited)
| Common Stock |
| Accumulated Other Comprehensive Income (Loss) |
| ||||||||||||||||||||||
Foreign | ||||||||||||||||||||||||||
Unamortized | Common Stock | Currency | Accumulated | Total | ||||||||||||||||||||||
Cost of Equity | and Paid-in | Retained | Translation | income (loss) | Pension | Stockholders’ | ||||||||||||||||||||
(In thousands except per share data) |
| Shares |
| Amount |
| Awards |
| Capital |
| Earnings |
| Adjustments |
| on derivatives |
| adjustments |
| Equity | ||||||||
Balances, December 31, 2021 |
| | $ | | $ | ( | $ | | $ | | $ | ( | $ | | $ | ( | $ | | ||||||||
Stock transactions under employee benefit stock plans |
| |
| | |
| | |||||||||||||||||||
Issuance of restricted stock, net of forfeitures |
| |
| |
| ( | ( |
| ( | |||||||||||||||||
Stock-based compensation expense |
| | |
| | |||||||||||||||||||||
Shares withheld for payment of employee payroll taxes | ( | ( | ( | ( | ||||||||||||||||||||||
Comprehensive (loss) income | ( | | | |||||||||||||||||||||||
Tax effect of derivative transactions | ( | ( | ||||||||||||||||||||||||
Net income |
|
| |
| | |||||||||||||||||||||
Dividends to stockholders - $ | ( | ( | ||||||||||||||||||||||||
Balances, March 31, 2022 |
| | $ | | $ | ( | $ | | $ | | $ | ( | $ | | $ | ( | $ | | ||||||||
| Common Stock |
| Accumulated Other Comprehensive Income (Loss) |
| ||||||||||||||||||||||
Foreign | ||||||||||||||||||||||||||
Unamortized | Common Stock | Currency | Accumulated | Total | ||||||||||||||||||||||
Cost of Equity | and Paid-in | Retained | Translation | income (loss) | Pension | Stockholders’ | ||||||||||||||||||||
| Shares |
| Amount |
| Awards |
| Capital |
| Earnings |
| Adjustments |
| on derivatives |
| adjustments |
| Equity | |||||||||
Balances, December 31, 2020 |
| | $ | | $ | ( | $ | | $ | | $ | ( | $ | ( | $ | ( | $ | | ||||||||
Stock transactions under employee benefit stock plans |
| |
| | |
| | |||||||||||||||||||
Issuance of restricted stock, net of forfeitures |
| |
| |
| ( | |
| | |||||||||||||||||
Stock-based compensation expense |
| | |
| | |||||||||||||||||||||
Shares withheld for payment of employee payroll taxes | ( | ( | ( | ( | ||||||||||||||||||||||
Comprehensive (loss) income | ( | | ( | |||||||||||||||||||||||
Tax effect of derivative transactions | ( | ( | ||||||||||||||||||||||||
Net income |
|
| |
| | |||||||||||||||||||||
Dividends to stockholders - $ | ( | ( | ||||||||||||||||||||||||
Balances, March 31, 2021 |
| | $ | | $ | ( | $ | | $ | | $ | ( | $ | ( | $ | ( | $ | | ||||||||
See accompanying notes to condensed consolidated financial statements.
3
ALLIED MOTION TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
For the three months ended | ||||||
March 31, | ||||||
| 2022 |
| 2021 | |||
Cash Flows From Operating Activities: | ||||||
Net income | $ | | $ | | ||
Adjustments to reconcile net income to net cash (used in) provided by operating activities | ||||||
Depreciation and amortization |
| |
| | ||
Deferred income taxes |
| |
| ( | ||
Stock-based compensation expense | | | ||||
Debt issue cost amortization recorded in interest expense | | | ||||
Other |
| |
| | ||
Changes in operating assets and liabilities, net of acquisition: | ||||||
Trade receivables |
| ( |
| ( | ||
Inventories |
| ( |
| | ||
Prepaid expenses and other assets |
| |
| | ||
Accounts payable |
| |
| | ||
Accrued liabilities |
| ( |
| ( | ||
Net cash (used in) provided by operating activities |
| ( |
| | ||
Cash Flows From Investing Activities: | ||||||
Purchase of property and equipment | ( | ( | ||||
Acquisitions |
| |
| — | ||
Net cash used in investing activities |
| ( |
| ( | ||
Cash Flows From Financing Activities: | ||||||
Principal payments of long-term debt and finance lease obligations | ( | — | ||||
Proceeds from issuance of long-term debt |
| |
| — | ||
Tax withholdings related to net share settlements of restricted stock | ( | ( | ||||
Net cash provided by (used in) financing activities |
| |
| ( | ||
Effect of foreign exchange rate changes on cash |
| ( |
| ( | ||
Net (decrease) increase in cash and cash equivalents |
| ( |
| | ||
Cash and cash equivalents at beginning of period |
| |
| | ||
Cash and cash equivalents at end of period | $ | | $ | | ||
Supplemental disclosure of cash flow information: | ||||||
Property, plant and equipment purchases in accounts payable or accrued expenses | $ | | $ | | ||
See accompanying notes to condensed consolidated financial statements.
4
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
1. BASIS OF PREPARATION AND PRESENTATION
Allied Motion Technologies Inc. (“Allied Motion” or the “Company”) is engaged in the business of designing, manufacturing and selling precision and specialty controlled motion components and systems, which include integrated system solutions as well as individual controlled motion products, to a broad spectrum of customers throughout the world primarily for the vehicle, medical, aerospace and defense, and industrial markets.
The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars using end of period exchange rates. Changes in reported amounts of assets and liabilities of foreign subsidiaries that occur as a result of changes in exchange rates between the foreign subsidiaries’ functional currencies and the U.S. dollar are included in foreign currency translation adjustment. Foreign currency translation adjustment is included in accumulated other comprehensive loss, a component of stockholders’ equity in the accompanying condensed consolidated statements of stockholders’ equity. Revenue and expense transactions use an average rate prevailing during the month of the related transaction. Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency of each of the foreign subsidiaries are included in the results of operations as incurred in other (income) expense, net.
The condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and include all adjustments which are, in the opinion of management, necessary for a fair presentation. Certain information and footnote disclosures normally included in financial statements which are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures herein are adequate to make the information presented not misleading. The financial data for the interim periods may not necessarily be indicative of results to be expected for the year.
The preparation of financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities as well as disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.
It is suggested that the accompanying condensed consolidated financial statements be read in conjunction with the Consolidated Financial Statements and related Notes to such statements included in the Annual Report on Form 10-K for the year ended December 31, 2021 that was previously filed by the Company.
Twinsburg Consolidation
In September 2021, the Company announced its plans to consolidate its manufacturing facility in Twinsburg, Ohio with its Watertown, New York and Reynosa, Mexico facilities in 2022. Costs of $
5
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
2. REVENUE RECOGNITION
Performance Obligations
Performance Obligations Satisfied at a Point in Time
The Company considers control of most products to transfer at a single point in time when control is transferred to the customer, generally when the products are shipped in accordance with an agreement and/or purchase order. Control is defined as the ability to direct the use of and obtain substantially all of the remaining benefits of the product.
The Company satisfies its performance obligations under a contract with a customer by transferring goods and services in exchange for monetary consideration from the customer. The Company considers the customer’s purchase order, and the Company’s corresponding sales order acknowledgment as the contract with the customer. For some customers, control, and a sale, is transferred at a point in time when the product is delivered to a customer.
Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.
Nature of Goods and Services
The Company sells component and integrated controlled motion solutions to end customers and original equipment manufacturers (“OEM’s”) through the Company’s own direct sales force and authorized manufacturers’ representatives and distributors. The Company’s products include brushed and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products. The Company’s target markets include Vehicle, Medical, Aerospace & Defense and Industrial.
Determining the Transaction Price
The majority of the Company’s contracts have an original duration of less than one year. For these contracts, the Company applies the practical expedient and therefore does not consider the effects of the time value of money. For multiyear contracts, the Company uses judgment to determine whether there is a significant financing component. These contracts are generally those in which the customer has made an up-front payment. Contracts that management determines to include a significant financing component are discounted at the Company’s incremental borrowing rate. The Company incurs interest expense and accrues a contract liability. As the Company satisfies performance obligations and recognizes revenue from these contracts, interest expense is recognized simultaneously. Management does not have any contracts that include a significant financing component as of March 31, 2022.
Disaggregation of Revenue
The Company disaggregates revenue from contracts with customers into geographical regions and target markets. The Company determines that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. As noted below in Note 17, Segment Information, the Company’s business consists of
6
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
A disaggregation of revenue by target market and geography is provided below (in thousands):
Three months ended | ||||||
March 31, | ||||||
Target Market |
| 2022 |
| 2021 | ||
Vehicle | $ | | $ | | ||
Industrial |
| |
| | ||
Medical |
| |
| | ||
Aerospace & Defense |
| |
| | ||
Other |
| |
| | ||
Total | $ | | $ | | ||
Three months ended | ||||||
March 31, | ||||||
Geography |
| 2022 |
| 2021 | ||
North America (primarily U.S.) | $ | | $ | | ||
Europe |
| |
| | ||
Asia-Pacific |
| |
| | ||
Total | $ | | $ | | ||
Contract Balances
When the timing of the Company’s delivery of product is different from the timing of the payments made by customers, the Company recognizes either a contract asset (performance precedes customer payment) or a contract liability (customer payment precedes performance). Typically, contracts are paid in arrears and are recognized as receivables after the Company considers whether a significant financing component exists.
The opening and closing balances of the Company’s contract liabilities are as follows (in thousands):
| March 31, |
| December 31, | |||
2022 | 2021 | |||||
Contract liabilities in accrued liabilities | $ | | $ | | ||
Contract liabilities in other long-term liabilities | | | ||||
$ | | $ | | |||
The difference between the opening and closing balances of the Company’s contract liabilities primarily results from the timing difference between the Company’s performance and the customer’s payment. In the three months ended March 31, 2022, the Company recognized revenue of $
Significant Payment Terms
The Company’s contracts with its customers state the final terms of the sale, including the description, quantity, and price of each product or service purchased. Payments are typically due in full within 30-60 days of delivery. Since the customer agrees to a stated rate and price in the contract that do not vary over the contract, the majority of contracts do not contain variable consideration.
Returns, Refunds, and Warranties
In the normal course of business, the Company does not accept product returns unless the item is defective as manufactured. The Company establishes provisions for estimated returns and warranties. All contracts include a standard warranty clause to guarantee that the product complies with agreed specifications.
7
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
3. INVENTORIES
Inventories include costs of materials, direct labor and manufacturing overhead, and are stated at the lower of cost (first-in, first-out basis) or net realizable value, as follows (in thousands):
| March 31, |
| December 31, | |||
2022 | 2021 | |||||
Parts and raw materials | $ | | $ | | ||
Work-in-process |
| |
| | ||
Finished goods |
| |
| | ||
$ | | $ | | |||
4. PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment is classified as follows (in thousands):
|
| March 31, |
| December 31, | ||||
Useful lives | 2022 | 2021 | ||||||
Land | $ | | $ | | ||||
Building and improvements |
|
| |
| | |||
Machinery, equipment, tools and dies |
|
| |
| | |||
Construction work in progress | | | ||||||
Furniture, fixtures and other |
|
| |
| | |||
| |
| | |||||
Less accumulated depreciation |
| ( |
| ( | ||||
Property, plant and equipment, net | $ | | $ | | ||||
Depreciation expense was approximately $
5. GOODWILL
The change in the carrying amount of goodwill for the three months ended March 31, 2022 is as follows (in thousands):
March 31, | ||
2022 | ||
Beginning balance | $ | |
Impact of measurement period adjustments of 2021 acquisitions | | |
Effect of foreign currency translation |
| ( |
Ending balance | $ | |
On November 2, 2021, the Company acquired
The initial purchase price, collectively, for ORMEC and ALIO was $
8
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
months ended March 31, 2022, a settlement of certain closing working capital amounts resulted in a cash inflow of $
The acquisition of ALIO includes contingent consideration initially measured at a fair value of $
6. INTANGIBLE ASSETS
Intangible assets on the Company’s condensed consolidated balance sheets consist of the following (in thousands):
March 31, 2022 | December 31, 2021 | |||||||||||||||||||
|
| Gross |
| Accumulated |
| Net Book |
| Gross |
| Accumulated |
| Net Book | ||||||||
Life | Amount | Amortization | Value | Amount | Amortization | Value | ||||||||||||||
Customer lists |
| $ | | $ | ( | $ | | $ | | $ | ( | $ | | |||||||
Trade name |
|
| |
| ( |
| |
| |
| ( |
| | |||||||
Design and technologies |
|
| |
| ( |
| |
| |
| ( |
| | |||||||
Total | $ | | $ | ( | $ | | $ | | $ | ( | $ | | ||||||||
Amortization expense for intangible assets was $
Estimated future intangible asset amortization expense as of March 31, 2022 is as follows (in thousands):
Estimated | |||
| Amortization Expense | ||
Remainder of 2022 | $ | | |
2023 |
| | |
2024 |
| | |
2025 | | ||
2026 |
| | |
2027 | | ||
Thereafter |
| | |
Total estimated amortization expense | $ | | |
7. STOCK-BASED COMPENSATION
Stock Incentive Plans
The Company’s Stock Incentive Plans provide for the granting of stock awards, including restricted stock, stock options and stock appreciation rights, to employees and non-employees, including directors of the Company.
9
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
Restricted Stock
For the three months ended March 31, 2022,
The following is a summary of restricted stock activity for the three months ended March 31, 2022:
Number of | ||
| shares | |
Outstanding at beginning of period |
| |
Awarded |
| |
Vested |
| ( |
Forfeited |
| ( |
Outstanding at end of period |
| |
Stock-based compensation expense, net of forfeitures, of $
8. ACCRUED LIABILITIES
Accrued liabilities consist of the following (in thousands):
March 31, | December 31, | |||||
| 2022 |
| 2021 | |||
Compensation and fringe benefits | $ | | $ | | ||
Accrued business acquisition consideration |
| |
| | ||
Warranty reserve |
| |
| | ||
Income taxes payable | | | ||||
| | |||||
| — | |||||
Deferred revenue | | | ||||
Other accrued expenses |
| |
| | ||
$ | | $ | | |||
9. DEBT OBLIGATIONS
Debt obligations consisted of the following (in thousands):
March 31, | December 31, | |||||
| 2022 |
| 2021 | |||
Long-term Debt | ||||||
Revolving Credit Facility, long-term (1) | $ | | $ | | ||
Unamortized debt issuance costs | ( | ( | ||||
Finance lease obligations - noncurrent | | — | ||||
Long-term debt | $ | | $ | | ||
(1) | The effective rate of the Amended Revolving Facility is |
10
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
Amended Revolving Credit Facility
The First Amended and Restated Credit Agreement (the “Amended Credit Agreement”) includes a $
Borrowings under the Amended Revolving Facility bear interest at the LIBOR or EURIBOR Rate (as defined in the Amended Credit Agreement) plus a margin of
The Amended Credit Agreement contains certain financial covenants related to minimum interest coverage, Total Leverage Ratio, and non-material subsidiaries assets to consolidated total assets at the end of each quarter. The Amended Credit Agreement also includes other covenants and restrictions, including limits on the amount of additional indebtedness, and restrictions on the Company’s ability to merge or sell all, or substantially all, of its assets. Under the provisions of the Amended Credit Agreement, the Company may elect to increase its Leverage Ratio to a
As of March 31, 2022, the unused Amended Revolving Facility was $
Other
The China Credit Facility provides credit of $
10. DERIVATIVE FINANCIAL INSTRUMENTS
The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, and foreign exchange risk primarily through the use of derivative financial instruments.
Beginning in the first quarter of 2021, the Company began entering into foreign currency contracts with maturities to hedge its short-term balance sheet exposure, primarily intercompany, that are denominated in currencies (Euro, Mexican Peso, New Zealand Dollar, Chinese Renminbi, Swedish Krona) other than the subsidiary’s functional currency and are adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in other expense (income), net in the condensed consolidated statements of income and comprehensive income. To minimize foreign currency exposure, the Company had foreign currency contracts with notional amounts of $
11
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
consolidated statements of income and comprehensive income. During three months ended March 31, 2022, the Company had gains of $
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements on its variable-rate debt. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. In February 2017, the Company entered into
The changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income (loss) and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. During 2022 and 2021, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.
The Company estimates that $
The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the condensed consolidated balance sheets as of March 31, 2022 and December 31, 2021 (in thousands):
Asset Derivatives | ||||||||
Fair value as of: | ||||||||
Derivatives designated as | Balance Sheet | March 31, | December 31, | |||||
hedging instruments |
| Location |
| 2022 |
| 2021 | ||
Foreign currency contracts | Prepaid expenses and other assets | $ | | $ | | |||
Interest rate products | Other long-term assets | | | |||||
$ | | $ | | |||||
Liability Derivatives | ||||||||
Fair value as of: | ||||||||
Derivatives designated as | Balance Sheet | March 31, | December 31, | |||||
hedging instruments |
| Location |
| 2022 |
| 2021 | ||
Interest rate products | Accrued liabilities | $ | — | $ | | |||
$ | — | $ | | |||||
The tables below present the effect of cash flow hedge accounting on other comprehensive income (loss) (“OCI”) for the three months ended March 31, 2022 and 2021 (in thousands):
Amount of pre-tax gain recognized | ||||||
in OCI on derivatives | ||||||
Derivatives in cash flow hedging relationships | Three months ended March 31, | |||||
| 2022 |
| 2021 | |||
Interest rate products | $ | | $ | | ||
12
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
Amount of pre-tax loss reclassified | ||||||
from accumulated OCI into income | ||||||
Location of (loss) gain reclassified | Three months ended March 31, | |||||
from accumulated OCI into income |
| 2022 |
| 2021 | ||
|
| |||||
Interest expense | $ | ( | $ | ( | ||
The table below presents the line items that reflect the effect of the Company’s derivative financial instruments on the condensed consolidated statements of income and comprehensive income for the three months ended March 31, 2022 and 2021 (in thousands):
Total amounts of income and expense | ||||||||
line items presented that reflect the | ||||||||
effects of cash flow hedges recorded | ||||||||
Three months ended March 31, | ||||||||
Derivatives designated as hedging instruments |
| Income Statement Location |
| 2022 |
| 2021 | ||
Interest rate products |
| Interest Expense | $ | | $ | | ||
The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of March 31, 2022 and December 31, 2021. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented in the condensed consolidated balance sheets (in thousands):
Derivative assets:
Net amounts | ||||||||||||||||||
Gross amounts | of assets | Gross amounts not offset in the consolidated | ||||||||||||||||
As of | Gross amounts | offset in the | presented in the | balance sheets | ||||||||||||||
March 31, | of recognized | consolidated | consolidated | Financial | Cash collateral | |||||||||||||
2022 |
| assets |
| balance sheets |
| balance sheets |
| instruments |
| received |
| Net amount | ||||||
Derivatives | $ | | $ | ( | $ | | $ | — | $ | — | $ | | ||||||
Net amounts | ||||||||||||||||||
Gross amounts | of assets | Gross amounts not offset in the consolidated | ||||||||||||||||
As of | Gross amounts | offset in the | presented in the | balance sheets | ||||||||||||||
December 31, | of recognized | consolidated | consolidated | Financial | Cash collateral | |||||||||||||
2021 |
| assets |
| balance sheets |
| balance sheets |
| instruments |
| received |
| Net amount | ||||||
Derivatives | $ | | $ | ( | $ | | $ | — | $ | — | $ | | ||||||
Derivative liabilities:
Net amounts | ||||||||||||||||||
Gross amounts | of liabilities | Gross amounts not offset in the consolidated | ||||||||||||||||
As of | Gross amounts | offset in the | presented in the | balance sheets | ||||||||||||||
December 31, | of recognized | consolidated | consolidated | Financial | Cash collateral | |||||||||||||
2021 |
| liabilities |
| balance sheets |
| balance sheets |
| instruments |
| received |
| Net amount | ||||||
Derivatives | $ | | $ | — | $ | | $ | — | $ | — | $ | | ||||||
The Company has agreements with each of its derivative counterparties that contain a provision where if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligations.
13
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
11. FAIR VALUE
Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.
The guidance establishes a framework for measuring fair value which utilizes observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. Preference is given to observable inputs.
These two types of inputs create the following three - level fair value hierarchy:
Level 1: | Quoted prices for identical assets or liabilities in active markets. |
Level 2: | Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model - derived valuations whose inputs or significant value drivers are observable. |
Level 3: | Significant inputs to the valuation model that are unobservable. |
The Company’s financial assets and liabilities include cash and cash equivalents, accounts receivable, debt obligations, accounts payable, and accrued liabilities. The carrying amounts reported in the condensed consolidated balance sheets for these assets and liabilities approximate their fair value because of the immediate or short-term maturities of these financial instruments.
The following tables presents the Company’s financial assets that are accounted for at fair value on a recurring basis as of March 31, 2022 and December 31, 2021, respectively, by level within the fair value hierarchy (in thousands):
March 31, 2022 | |||||||||
| Level 1 |
| Level 2 |
| Level 3 | ||||
Assets (liabilities) | |||||||||
Pension plan assets | $ | | $ | — | $ | — | |||
Deferred compensation plan assets |
| |
| — |
| — | |||
Foreign currency hedge contracts |
| — |
| |
| — | |||
Interest rate swaps, net |
| — |
| |
| — | |||
Contingent consideration |
| — |
| — |
| ( | |||
December 31, 2021 | |||||||||
| Level 1 |
| Level 2 |
| Level 3 | ||||
Assets (liabilities) | |||||||||
Pension plan assets | $ | | $ | — | $ | — | |||
Deferred compensation plan assets |
| |
| — |
| — | |||
Foreign currency hedge contracts |
| — |
| |
| — | |||
Interest rate swaps, net |
| — |
| |
| — | |||
Contingent consideration |
| — |
| — |
| ( | |||
The contingent consideration fair value measurement in connection with the acquisition of ALIO Industries in the fourth quarter of 2021 is based on significant inputs not observable in the market and therefore constitute Level 3 inputs within the fair value hierarchy. The Company determines the initial fair value of contingent consideration liabilities using a Monte Carlo valuation model, which involves a simulation of future earnings generated during the earn out-period using management’s best estimates, or a probability-weighted discounted cash flow analysis. There were
14
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
12. INCOME TAXES
The income tax provision for interim periods is determined using an estimate of the annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the estimate of the annual effective tax rate is updated, and if the estimated effective tax rate changes, a cumulative adjustment is made. There is potential for volatility of the effective tax rate due to several factors, including changes in the mix of the pre-tax income and the jurisdictions to which it relates, changes in tax laws, settlements with taxing authorities and foreign currency fluctuations.
The effective income tax rate was
13. LEASES
The Company has operating leases for office space, manufacturing equipment, computer equipment and automobiles. Many leases include one or more options to renew, some of which include options to extend the leases for a long-term period, and some leases include
Supplemental cash flow information related to the Company’s operating and finance leases for the three months ended March 31, 2022 and 2021 was as follows (in thousands):
March 31, | |||||||
2022 | 2021 | ||||||
Cash paid for amounts included in the measurement of operating leases |
| $ | |
| $ | |
|
Cash paid for amounts included in the measurement of finance lease obligations |
| $ | |
| $ | — |
|
Right of use assets obtained in exchange for operating lease obligations | $ | | $ | | |||
Right of use assets obtained in exchange for finance lease obligations | $ | | $ | — | |||
The Company’s finance lease obligations relate to a manufacturing facility. As of March 31, 2022, finance lease assets of $
The following table presents the maturity of the Company’s operating and finance lease liabilities as of March 31, 2022 (in thousands):
| Operating Leases | Finance Leases | ||||
Remainder of 2022 |
| $ | | $ | | |
2023 |
| | | |||
2024 |
| |
| | ||
2025 |
| |
| | ||
2026 | | | ||||
2027 | | | ||||
Thereafter |
| |
| | ||
Total undiscounted cash flows | $ | | $ | | ||
Less: present value discount | ( | ( | ||||
Total lease liabilities | $ | | $ | | ||
15
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
As of March 31, 2022, the Company has entered into leases with future minimum lease payments of $
The Company leases certain facilities from companies for which a member of management is a part owner. In connection with such leases, the Company made fixed minimum lease payments to the lessor of $
14. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Accumulated Other Comprehensive Income (Loss) (“AOCI”) for the three months ended March 31, 2022 and 2021 is comprised of the following (in thousands):
Foreign Currency | |||||||||||||||
Defined Benefit | Tax Effect of | Translation | |||||||||||||
| Plan Liability |
| Cash Flow Hedges |
| Cash Flow Hedges |
| Adjustment |
| Total | ||||||
At December 31, 2021 | $ | ( | $ | | $ | ( | $ | ( | $ | ( | |||||
Unrealized gain on cash flow hedges | — | | ( | — | | ||||||||||
Amounts reclassified from AOCI | — | | ( | — | | ||||||||||
Foreign currency translation loss | — | — | — | ( | ( | ||||||||||
At March 31, 2022 | $ | ( | $ | | $ | ( | $ | ( | $ | ( | |||||
Foreign Currency | |||||||||||||||
Defined Benefit | Tax Effect of | Translation | |||||||||||||
| Plan Liability |
| Cash Flow Hedges |
| Cash Flow Hedges |
| Adjustment |
| Total | ||||||
At December 31, 2020 | $ | ( | $ | ( | $ | | $ | ( | $ | ( | |||||
Unrealized gain on cash flow hedges | — | | ( | — | | ||||||||||
Amounts reclassified from AOCI | — | | ( | — | | ||||||||||
Foreign currency translation loss | — | — | — | ( | ( | ||||||||||
At March 31, 2021 | $ | ( | $ | ( | $ | | $ | ( | $ | ( | |||||
The realized losses relating to the Company’s interest rate swap hedges were reclassified from AOCI and included in interest expense in the condensed consolidated statements of income and comprehensive income.
15. DIVIDENDS PER SHARE
The Company declared a quarterly dividend of $
16
ALLIED MOTION TECHNOLOGIES INC.
UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
16. EARNINGS PER SHARE
Basic and diluted weighted-average shares outstanding are as follows (in thousands):
Three months ended | ||||
March 31, | ||||
| 2022 |
| 2021 | |
Basic weighted average shares outstanding |
| |
| |
Dilutive effect of potential common shares |
| |
| |
Diluted weighted average shares outstanding |
| |
| |
For the three months ended March 31, 2022 and 2021, the anti-dilutive common shares excluded from the calculation of diluted earnings per share were immaterial.
17. SEGMENT INFORMATION
The Company operates in
Revenues for the three months ended March 31, 2022 was comprised of
Identifiable foreign fixed assets were $
For the three months ended March 31, 2022 and 2021, one customer accounted for
17
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
All statements contained herein that are not statements of historical fact constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements, and may contain the word “believe,” “anticipate,” “expect,” “project,” “intend,” “will continue,” “will likely result,” “should” or words or phrases of similar meaning. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from the expected results described in the forward-looking statements. The risks and uncertainties include those associated with: the domestic and foreign general business and economic conditions in the markets we serve, including political and currency risks and adverse changes in local legal and regulatory environments; the severity, magnitude and duration of the COVID-19 pandemic, including impacts of the pandemic and of businesses’ and governments’ responses to the pandemic on our operations and personnel, and on commercial activity and demand across our and our customers’ businesses, and on global supply chains; our inability to predict the extent to which the COVID-19 pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position, the prices of our securities and the achievement of our strategic objectives; the introduction of new technologies and the impact of competitive products; the ability to protect the Company’s intellectual property; our ability to sustain, manage or forecast our growth and product acceptance to accurately align capacity with demand; the continued success of our customers and the ability to realize the full amounts reflected in our order backlog as revenue; the loss of significant customers or the enforceability of the Company’s contracts in connection with a merger, acquisition, disposition, bankruptcy, or otherwise; our ability to meet the technical specifications of our customers; the performance of subcontractors or suppliers and the continued availability of parts and components; failure of a key information technology system, process or site or a breach of information security, including a cybersecurity breach, ransomware, or failure of one or more key information technology systems, networks, processes, associated sites or service providers; changes in government regulations; the availability of financing and our access to capital markets, borrowings, or financial transactions to hedge certain risks; the ability to attract and retain qualified personnel, and in particular those who can design new applications and products for the motion industry; the ability to implement our corporate strategies designed for growth and improvement in profits including to identify and consummate favorable acquisitions to support external growth and the development of new technologies; the ability to successfully integrate an acquired business into our business model without substantial costs, delays, or problems; our ability to control costs, including the establishment and operation of low cost region manufacturing and component sourcing capabilities; and in the Company’s Annual Report in Form 10 K. Actual results, events and performance may differ materially from the Company’s forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements as a prediction of actual results. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict the occurrence of those matters or the manner in which they may affect us. The Company has no obligation or intent to release publicly any revisions to any forward-looking statements, whether as a result of new information, future events, or otherwise.
New risk factors emerge from time to time and it is not possible for management to predict all such risk factors, nor can it assess the impact of all such risk factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company’s expectations, beliefs and projections are believed to have a reasonable basis; however, the Company makes no assurance that expectations, beliefs or projections will be achieved.
Overview
We are a global company that designs, manufactures and sells precision and specialty controlled motion products and solutions used in a broad range of industries. Our target markets include Vehicle, Medical, Aerospace & Defense (A&D), and Industrial. We are headquartered in Amherst, NY, and have operations in the United States, Canada, Mexico, Europe and Asia-Pacific. We are known worldwide for our expertise in electro-magnetic, mechanical and electronic motion technology. We sell component and integrated controlled motion solutions to end customers and OEMs through our own direct sales force and authorized manufacturers’ representatives and distributors. Our products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products.
18
Business Environment
COVID-19
The ongoing impact of Coronavirus (“COVID-19”) and its variants has created significant impacts and disruptions to the U.S. and global economies and are likely to do so for the foreseeable future. We expect that COVID-19 will continue to adversely affect portions of our business, including our global supply chain and manufacturing operations. We experienced reductions in customer demand in certain of our served markets and increases in demand in other of these markets during the first quarter of 2022 due to COVID-19. The operational ability of our suppliers to provide the necessary quantity of materials on a timely basis has been reduced, which has impacted the predictability of our global supply chain, and resulted in some increased costs to secure and place materials into production and forced us to delay product shipments. Throughout 2022, we expect the impact of COVID-19 on our operations will continue to challenge certain aspects of our business, particularly our global supply chain and our ability to hire direct labor. Certain materials and components used in our products are required and qualified to be sourced from a single or a limited number of suppliers. Any interruption in the supply from any supplier that serves as a sole source could delay product shipments and have a material adverse effect on our business.
In response to COVID-19, we have taken and will continue to take proactive, aggressive action to protect the health and safety of our employees, customers, partners, suppliers and communities. We continue to follow rigorous safety measures in all of our sites, including social distancing protocols, incorporating a work from home model at certain times for those employees that do not need to be physically present to perform their work, limiting travel, implementing temperature checks at the entrances to our facilities where required, extensively and frequently disinfecting our workspaces and providing masks and other protective equipment to those employees who must be physically present. These measures have been implemented on a worldwide basis and have been adjusted prudently as requirements and conditions change. We will continue to monitor and act in accordance with government authorities requirements or recommendations and evolving best practices.
Our Company provides essential and important products, including some that our customers rely on to address COVID-19. We manufacture and deliver critical motion control components, including electronic drives, motors and control assemblies to manufacturers of medical equipment including respirators, ventilators, infusion pumps, medical fluid pumps and other breathing assist equipment required to care for patients with respiratory issues including COVID-19. We are a long-term, qualified supplier to leading medical device manufacturers of ventilators and respirators around the world.
While demand for certain items, such as ventilators, has returned to normalized levels in 2022, we continue to provide solutions to suppliers of other types of medical equipment, including surgical tools and equipment, surgical robots, diagnostic equipment, test equipment, patient mobility and rehabilitation equipment, hospital beds and mobile equipment carts.
Our worldwide locations are considered to be essential suppliers to our customers and therefore most of our locations have remained substantially operational throughout the outbreak while implementing the enhanced safety procedures.
There have been recent COVID-19 related lockdowns in certain areas of China that have generally impacted the timing of shipments into and out of certain ports. These lockdowns have not significantly impacted our production facilities, however we are continuing to monitor the situation.
Our Amended Credit Agreement includes a $225 million revolving credit facility through February 2025. Through this amendment we have lowered our cost of debt, and have secured more favorable covenants. This liquidity preserves our financial flexibility during the pandemic and subsequent to it. We believe that our cash flows from operations and borrowing capacity are sufficient to support our short and long-term liquidity needs.
To conserve cash and maximize operational efficiency while supporting growth plans, we continue to align variable costs with demand, maintain and enhance key engineering capabilities, and control discretionary spending. The Company continues to closely monitor events and conditions resulting from COVID-19.
The extent of the impact of the COVID-19 outbreak on our operational and financial performance will continue to depend on future developments, including the duration and spread of the virus and variants, the potential for additional waves, its impact on our customers, suppliers and the range of governmental reactions to the pandemic, which cannot be predicted at this time. We will continue to proactively respond to the situation and will take further actions as warranted to alter our business operations as necessary.
19
Recent Events
The current conflict in Ukraine has created general economic uncertainty with regard to energy and other commodity prices, interest rates, markets served, and our supply chain. The conflict has resulted in increased energy and component costs in our European locations, as well as extending the time for component shipments between Europe and Asia-Pacific. We continue to monitor developments as they unfold in order to react accordingly. The impact of the conflict on our operational and financial performance will depend on future developments that cannot be predicted, however, the Company does not believe the impacts to be material at this time.
Twinsburg Consolidation
In September 2021, the Company announced its plans to consolidate its manufacturing facility in Twinsburg, Ohio with its Watertown, New York and Reynosa, Mexico facilities in 2022. Costs of $488 are included in business development in the condensed consolidated statement of income and comprehensive income for the three months ended March 31, 2021 related to this consolidation. Costs incurred in connection with this initiative have included accelerated lease costs, severance and other payroll related costs, legal costs, accelerated depreciation, and costs to relocate inventory and machinery and equipment. This initiative is expected to be completed during the second quarter of 2022.
Operating Results
Three months ended March 31, 2022 compared to three months ended March 31, 2021
For the three months ended |
| 2022 vs. 2021 | ||||||||||
March 31, | Variance |
| ||||||||||
(Dollars in thousands, except per share data) |
| 2022 |
| 2021 | $ |
| % | |||||
Revenues | $ | 114,785 | $ | 101,677 | $ | 13,108 | 13 | % | ||||
Cost of goods sold |
| 81,325 | 71,609 |
| 9,716 | 14 | % | |||||
Gross profit |
| 33,460 |
| 30,068 |
| 3,392 | 11 | % | ||||
Gross margin percentage |
| 29.2 | % |
| 29.6 | % |
|
|
| |||
Operating costs and expenses: |
|
|
|
|
|
|
| |||||
Selling |
| 5,031 | 4,218 |
| 813 | 19 | % | |||||
General and administrative |
| 11,496 | 10,748 |
| 748 | 7 | % | |||||
Engineering and development |
| 9,385 | 6,959 |
| 2,426 | 35 | % | |||||
Business development |
| 848 | 19 |
| 829 | NM | ||||||
Amortization of intangible assets |
| 2,434 | 1,512 |
| 922 | 61 | % | |||||
Total operating costs and expenses |
| 29,194 |
| 23,456 |
| 5,738 | 24 | % | ||||
Operating income |
| 4,266 |
| 6,612 |
| (2,346) | (35) | % | ||||
Interest expense |
| 1,038 |
| 861 |
| 177 | 21 | % | ||||
Other expense (income), net |
| 45 |
| (119) |
| 164 | (138) | % | ||||
Total other expense |
| 1,083 |
| 742 |
| 341 | 46 | % | ||||
Income before income taxes |
| 3,183 |
| 5,870 |
| (2,687) | (46) | % | ||||
Income tax (provision) benefit |
| (679) |
| 6,057 |
| (6,736) | (111) | % | ||||
Net income | $ | 2,504 | $ | 11,927 | $ | (9,423) | (79) | % | ||||
|
|
|
|
|
|
| ||||||
Effective tax rate |
| 21.3 | % |
| (103.2) | % | ||||||
Diluted earnings per share | $ | 0.16 | $ | 0.83 | $ | (0.67) | (81) | % | ||||
Bookings | $ | 155,295 | $ | 114,644 | $ | 40,651 | 35 | % | ||||
Backlog | $ | 289,295 | $ | 152,262 | $ | 137,033 | 90 | % | ||||
REVENUES: The increase in revenues during the first quarter 2022 reflects increases in our Industrial and A&D served markets and includes the impact of the three acquisitions that were completed in the fourth quarter of 2021. Our sales for the period ended March 31, 2022 were comprised of 56% to U.S. customers and 44% to customers primarily in Europe, Canada and Asia-Pacific. The overall increase in revenue was due to a 16% volume increase offset partially by a 3% unfavorable currency impact. Organic growth was 5.3% during the first quarter 2022. See information included in “Non – GAAP Measures” below for a discussion of the non-GAAP measure and reconciliation of revenue to revenue excluding foreign currency impacts.
20
ORDER BOOKINGS AND BACKLOG: The 35% increase in orders in the first quarter 2022 compared to 2021 is due to a 39% increase in volume, offset partially by a 4% unfavorable currency impact. The increase in bookings during the first quarter 2022 compared to 2021 is impacted by the three acquisitions completed during the fourth quarter 2021 along with organic growth notably in our Industrial markets.
GROSS PROFIT AND GROSS MARGIN: Gross profit increased to $33,460 in the first quarter of 2022 from $30,068 in the first quarter of 2021 driven by higher sales volume, including the recently completed acquisitions, however gross margins declined to 29.2% for 2022, compared to 29.6% for 2021. The decrease in gross margin percentage was largely driven by acquisition inventory step-up amortization of $778, higher material and labor costs including costs associated with addressing the disruptions in the global supply chain environment to meet the needs of our customers.
SELLING EXPENSES: Selling expenses increased 19% during the first quarter 2022 compared to 2021 primarily due to increased costs in connection with our recently completed acquisitions as well as sales commissions related to the increased revenue growth. Selling expenses as a percentage of revenues were comparable at 4% during 2022 and 2021.
GENERAL AND ADMINISTRATIVE EXPENSES: General and administrative expenses increased by 7% during the first quarter 2022 compared to 2021 due primarily to increased costs related to the inclusion of our recent acquisitions. As a percentage of revenues, general and administrative expenses were 10% and 11% in 2022 and 2021, respectively.
ENGINEERING AND DEVELOPMENT EXPENSES: Engineering and development expenses increased by 35% in the first quarter of 2022 compared to 2021. The increase is due primarily to the inclusion and nature of our recent acquisitions along with our continued investment in new product development. As a percentage of revenues, engineering and development expenses were 8% for the three months ended March 31, 2022 compared to 7% for the three months ended March 31, 2021.
BUSINESS DEVELOPMENT COSTS: The increase in business development costs in the first quarter 2022 compared to 2021 is due to increased costs related to acquisition-related activities, as well as costs related to the Twinsburg plant consolidation.
AMORTIZATION OF INTANGIBLE ASSETS: Amortization of intangible assets increased in the first quarter 2022 compared to 2021 due to incremental intangible amortization attributable to the three business acquisitions completed in the fourth quarter of 2021.
INTEREST EXPENSE: Interest expense increased by 21% in the first quarter of 2022 compared to 2021 primarily due to an increase in average debt levels.
INCOME TAXES: For the three months ended March 31, 2022 and 2021, the effective income tax rate was 21.3% and (103.2%), respectively. The effective tax rate for the three months ended March 31, 2022 and 2021 includes a discrete tax benefit of (7.2%) and (130.5%), respectively. For the three months ended March 31, 2022 the discrete tax benefit related primarily to the reversal of uncertain tax positions. The discrete benefit in the three months ended March 31, 2021 is related primarily to the recognition of net operating loss carryforwards resulting from tax legislation enacted in New Zealand during the period which changed our ability to use the carryforwards in future periods . The Company expects its income tax rate for the full year 2022 to be approximately 24% to 26%.
NET INCOME AND ADJUSTED NET INCOME: Net income decreased during the first quarter of 2022 compared to 2021 primarily due to the effect of a $7,373 discrete income tax benefit in the first quarter of 2021 that was not present in the first quarter of 2022 as well as incremental business development costs and amortization of intangible assets of $829 and $922, respectively, due to acquisition-related activity.
Adjusted net income for the quarters ended March 31, 2022 and 2021 was $3,788 and $4,560, respectively. Adjusted diluted earnings per share for the first quarter of 2022 and 2021 were $0.24 and $0.32, respectively. Adjusted net income and adjusted diluted earnings per share are non-GAAP measures. See information included in “Non–GAAP Measures” below for a discussion of the non-GAAP measure and reconciliation of net income to Adjusted net income and diluted earnings per share to Adjusted diluted earnings per share.
EBITDA AND ADJUSTED EBITDA: EBITDA was $10,656 for the first quarter 2022 compared to $11,162 for the first quarter 2021. Adjusted EBITDA was $12,903 and $11,966 for the first quarters of 2022 and 2021, respectively. EBITDA and Adjusted EBITDA are non-GAAP measures. EBITDA consists of income before interest expense, provision for income taxes, and depreciation and amortization. Adjusted EBITDA also excludes stock-based compensation expense, foreign currency gain/loss and certain other items. Refer to information included in “Non-GAAP Measures” below for a discussion of the non-GAAP measure and a reconciliation of net income to EBITDA and Adjusted EBITDA.
21
Non-GAAP Measures
Revenue excluding foreign currency exchange impacts, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted earnings per share are provided for information purposes only and are not measures of financial performance under GAAP.
Management believes the presentation of these financial measures reflecting non-GAAP adjustments provides important supplemental information to investors and other users of our financial statements in evaluating the operating results of the Company as distinct from results that include items that are not indicative of ongoing operating results. In particular, those charges and credits that are not directly related to operating unit performance, and that are not a helpful measure of the performance of our underlying business particularly in light of their unpredictable nature. These non-GAAP disclosures have limitations as analytical tools, should not be viewed as a substitute for revenue and net income determined in accordance with GAAP, and should not be considered in isolation or as a substitute for analysis of the Company’s results as reported under GAAP, nor is it necessarily comparable to non-GAAP performance measures that may be presented by other companies. In addition, supplemental presentation should not be construed as an inference that the Company’s future results will be unaffected by similar adjustments to net income determined in accordance with GAAP.
The Company believes that revenue excluding foreign currency exchange impacts is a useful measure in analyzing sales results. The Company excludes the effect of currency translation from revenue for this measure because currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends. The portion of revenue attributable to currency translation is calculated as the difference between the current period revenue and the current period revenue after applying foreign exchange rates from the prior period.
The Company believes EBITDA is often a useful measure of a Company’s operating performance and is a significant basis used by the Company’s management to measure the operating performance of the Company’s business because EBITDA excludes charges for depreciation, amortization and interest expense that have resulted from our debt financings, acquisitions, as well as our provision for income tax expense. EBITDA is frequently used as one of the bases for comparing businesses in the Company’s industry.
The Company also believes that Adjusted EBITDA provides helpful information about the operating performance of its business. Adjusted EBITDA excludes stock-based compensation expense, as well as business development costs, foreign currency gains/losses on short-term assets and liabilities, and other items that are not indicative of the Company’s core operating performance. EBITDA and Adjusted EBITDA do not represent and should not be considered as an alternative to net income, operating income, net cash provided by operating activities or any other measure for determining operating performance or liquidity that is calculated in accordance with GAAP.
Management uses Adjusted net income and Adjusted diluted earnings per share to assess the Company’s consolidated financial and operating performance. Adjusted net income and Adjusted diluted earnings per share are provided for informational purposes only and are not a measure of financial performance under GAAP. These measures help management make decisions that are expected to facilitate meeting current financial goals as well as achieving optimal financial performance. Adjusted net income provides management with a measure of financial performance of the Company based on operational factors as it removes the impact of certain non-routine items from the Company’s operating results. Adjusted diluted earnings per share provides management with an indication of how Adjusted net income would be reflected on a per share basis for comparison to the GAAP diluted earnings per share measure. Adjusted net income is a key metric used by senior management and the Company’s board of directors to review the consolidated financial performance of the business. This measure adjusts net income determined in accordance with GAAP to reflect changes in financial results associated with the highlighted expense and income items.
The Company’s calculation of revenues excluding foreign currency exchange impacts for the three months ended March 31, 2022 is as follows (in thousands):
Three months ended | |||
| March 31, 2022 | ||
Revenue as reported | $ | 114,785 | |
Currency impact unfavorable (favorable) |
| 3,229 | |
Revenue excluding foreign currency exchange impacts | $ | 118,014 | |
22
The Company’s calculation of EBITDA and Adjusted EBITDA for the three months ended March 31, 2022 and 2021 is as follows (in thousands):
| Three months ended |
| |||||
March 31, | |||||||
| 2022 |
| 2021 |
| |||
Net income as reported | $ | 2,504 | $ | 11,927 | |||
Interest expense |
| 1,038 |
| 861 | |||
Provision (benefit) for income tax |
| 679 |
| (6,057) | |||
Depreciation and amortization |
| 6,435 |
| 4,431 | |||
EBITDA |
| 10,656 |
| 11,162 | |||
Stock-based compensation expense |
| 1,349 |
| 797 | |||
Business development costs |
| 848 |
| 19 | |||
Foreign currency loss (gain) | 50 | (12) | |||||
Adjusted EBITDA | $ | 12,903 | $ | 11,966 | |||
The Company’s calculation of Adjusted net income and Adjusted diluted earnings per share for the three months ended March 31, 2022 and 2021 is as follows (in thousands except per share amounts):
| For the three months ended | |||||||||||
March 31, | ||||||||||||
|
| Per diluted |
|
| Per diluted | |||||||
2022 | share | 2021 | share | |||||||||
Net income as reported | $ | 2,504 | $ | 0.16 | $ | 11,927 | $ | 0.83 | ||||
Non-GAAP adjustments, net of tax |
|
|
|
|
|
|
|
| ||||
Discrete income tax benefit |
| — | — |
| (7,373) |
| (0.51) | |||||
Acquisition inventory step-up amortization - net |
| 596 | 0.04 |
| — |
| — | |||||
Foreign currency loss (gain) - net |
| 38 |
| — |
| (9) |
| — | ||||
Business development costs - net |
| 650 |
| 0.04 |
| 15 |
| — | ||||
Non-GAAP adjusted net income and diluted earnings per share | $ | 3,788 | $ | 0.24 | $ | 4,560 | $ | 0.32 | ||||
Liquidity and Capital Resources
The Company’s liquidity position as measured by cash and cash equivalents decreased by $5,544 to a balance of $16,919 at March 31, 2022 from December 31, 2021.
| 2022 vs. | ||||||||
Three Months Ended | 2021 | ||||||||
March 31, | Variance | ||||||||
| 2022 |
| 2021 |
| $ | ||||
Net cash (used in) provided by operating activities | $ | (13,396) | $ | 5,567 | $ | (18,963) | |||
Net cash used in investing activities | (2,293) |
| (3,076) |
| 783 | ||||
Net cash provided by (used in) financing activities | 10,221 |
| (256) |
| 10,477 | ||||
Effect of foreign exchange rates on cash | (76) |
| (641) |
| 565 | ||||
Net (decrease) increase in cash and cash equivalents | $ | (5,544) | $ | 1,594 | $ | (7,138) | |||
Of the $16,919 of cash and cash equivalents at March 31, 2022, $13,404 was located at our foreign subsidiaries and may be subject to withholding tax if repatriated back to the U.S.
During the three months ended March 31, 2022, the decrease in cash used in operating activities is primarily due to working capital needs, primarily for inventories and trade receivables. Cash used for inventories is primarily due to strategic decisions to secure critical components given the current supply chain environment.
Cash used in investing activities in the three months ended March 31, 2022 includes $2,478 for purchases of property and equipment compared to $3,076 during the three months ended March 31, 2021. Capital expenditures are expected to be between $15,000 and $20,000 for the full year 2022.
23
The increase in cash provided by financing activities in the three months ended March 31, 2022 compared to the three months ended March 31, 2021 is primarily a result of increased borrowings to fund working capital needs. At March 31, 2022, we had $169,716 of obligations under the Amended Revolving Facility, excluding deferred financing costs.
The Amended Credit Agreement contains certain financial covenants related to minimum interest coverage, total leverage ratio, and non-material subsidiaries assets to consolidated total assets at the end of each quarter. The Amended Credit Agreement also includes other covenants and restrictions, including limits on the amount of additional indebtedness, and restrictions on the ability to merge, consolidate or sell all, or substantially all, of our assets. Under the provisions of the Amended Credit Agreement, we may elect to increase our Leverage Ratio to a 4.0 to 1.0 ratio (a “Leverage Increase”) during the fiscal quarter in which a Material Acquisition (as defined in the Amended Credit Agreement) takes place and for the next three fiscal quarters. If the Material Acquisition occurs within the last 45 days of any fiscal quarter, the Leverage Increase is applicable for the following four fiscal quarters. We qualified for and elected the Leverage Increase as a result of the Spectrum Controls acquisition in the fourth quarter of 2021. We were in compliance with all covenants at March 31, 2022.
As of March 31, 2022, the unused Amended Revolving Facility was $55,284. The amount available to borrow may be lower and may vary from period to period based upon our debt and EBITDA levels, which impacts our covenant calculations. The Amended Credit Agreement matures in February 2025.
There were no borrowings under the China Facility during the three months ended March 31, 2022 and 2021, respectively.
The Company declared dividends of $0.025 and $0.02 per share during the first quarter 2022 and 2021, respectively. The Company’s working capital, capital expenditure and dividend requirements are expected to be funded from cash provided by operations and amounts available under the Amended Credit Agreement.
Although there is ongoing uncertainty related to the anticipated impact of COVID-19 and variants on our future results, we believe our diverse markets, our strong market position in many of our businesses, and the steps we have taken to strengthen our balance sheet leaves us well-positioned to manage our business through the crisis as it continues to unfold. We continually assess our liquidity and cash positions and have assessed the impact of COVID-19 on our Company. Based on our analysis, we believe our existing balances of cash, the flexibility of our Amended Credit Agreement and our currently anticipated operating cash flows will be more than sufficient to meet our cash needs arising in the ordinary course of business for the next twelve months.
Item 3. Qualitative and Quantitative Disclosures about Market Risk
Foreign Currency
We have international operations in The Netherlands, Sweden, Germany, China, Portugal, Canada, Czech Republic, Mexico, the United Kingdom and New Zealand which expose us to foreign currency exchange rate fluctuations due to transactions denominated in Euros, Swedish Krona, Chinese Renminbi, Canadian dollar, Czech Krona, Mexican pesos, British Pound Sterling, and New Zealand dollar, respectively. We continuously evaluate our foreign currency risk and we take action from time to time in order to best mitigate these risks. A hypothetical 10% change in the value of the U.S. dollar in relation to our most significant foreign currency exposures would have had an impact of approximately $4,200 on our first quarter 2021 sales. This amount is not indicative of the hypothetical net earnings impact due to partially offsetting impacts on cost of sales and operating expenses in those currencies. We estimate that foreign currency exchange rate fluctuations during the quarter ended March 31, 2022 decreased sales compared to the quarter ended March 31, 2021 by approximately $3,229.
We translate all assets and liabilities of foreign operations, where the U.S. dollar is not the functional currency, at the period-end exchange rate and translate sales and expenses at the average exchange rates in effect during the period. The net effect of these translation adjustments is recorded in the consolidated financial statements as comprehensive income. The translation adjustments were losses of $1,233 and $4,007 for the first quarter of 2022 and 2021, respectively. Translation adjustments are not adjusted for income taxes as they relate to permanent investments in our foreign subsidiaries. A hypothetical 10% change in the value of the U.S. dollar in relation to our most significant foreign currency net assets would have had an impact of approximately $11,000 on our foreign net assets as of March 31, 2022.
We have contracts to hedge our short-term balance sheet exposure, primarily intercompany, that are denominated in currencies (Euro, Mexican Peso, New Zealand Dollar, Chinese Renminbi, Swedish Krona) other than the subsidiary’s functional currency and are
24
adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in other (income) expense, net in the consolidated statements of income and comprehensive income. To minimize foreign currency exposure, the Company had foreign currency contracts with notional amounts of $12,656 at March 31, 2022. The foreign currency contracts are recorded in the condensed consolidated balance sheets at fair value and resulting gains or losses are recorded in other expense (income), net in the condensed consolidated statements of income and comprehensive income. During the quarter ended March 31, 2021, we recorded gains of $54 on foreign currency contracts which is included in other expense (income), net and generally offset the gains or losses from the foreign currency adjustments on the intercompany balances that are also included in other expense (income), net. Net foreign currency transaction gains and losses included in total other expense, net amounted to a loss of $50 and a gain of $12 for the first quarter of 2022 and 2021, respectively.
Interest Rates
Interest rates on our Amended Credit Agreement are based on the LIBOR or EURIBOR plus a margin of 1.00% to 1.75% (1.625% at March 31, 2021) or the Prime Rate plus a margin of 0% to 0.75% (0.625% at December 31, 2021), in each case depending on the Company’s ratio of total funded indebtedness to Consolidated EBITDA. We use interest rate derivatives to add stability to interest expense and to manage our exposure to interest rate movements. We primarily use interest rate swaps as part of our interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. In February 2017, the Company entered into three interest rate swaps with a combined notional amount of $40,000 that matured in February 2022. In March 2020, the Company entered into two additional interest rate swaps with a combined notional amount of $20,000 that increased to $60,000 in March 2022 and matures in December 2024. In March 2022 the Company entered into an additional interest rate swap with a notional amount of $40,000 that matures in December 2026.
As of March 31, 2022, we had $169,716 outstanding under the Amended Revolving Facility (excluding deferred financing fees), of which $100,000 is currently being hedged. Refer to Note 7, Debt Obligations, of the notes to consolidated financial statements for additional information about our outstanding debt. A hypothetical one percentage point (100 basis points) change in the Base Rate on the $99,716 of unhedged floating rate debt outstanding at March 31, 2021 would have an impact of approximately $249 on our interest expense for the first quarter of 2022.
Item 4. Controls and Procedures
Conclusion regarding the effectiveness of disclosure controls and procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer (principal accounting officer), evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2022. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Based on management’s evaluation of our disclosure controls and procedures as of March 31, 2022, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective.
Changes in internal control over financial reporting
During the quarter ended March 31, 2022, there were no changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
25
PART II. OTHER INFORMATION
Item 1A. Risk Factors
There have been no material changes to the risk factors disclosed in the Company’s Form 10-K for the year ended December 31, 2021, except to the extent factual information disclosed elsewhere in this Form 10-Q relates to such risk factors. For a full discussion of these risk factors, please refer to “Item 1A. Risk Factors” in the 2021 Annual Report and 10-K.
Item 5. Unregistered Sales of Equity Securities and Use of Proceeds
|
|
| Total Number of Shares |
| Maximum Number of Shares | ||||
Number of Shares | Average Price Paid | Purchased as Part of Publicly | that May Yet Be Purchased | ||||||
Period | Purchased (1) | per Share | Announced Plans or Programs | Under the Plans or Programs | |||||
01/01/22 to 01/31/22 |
| 1,110 | $ | 36.88 |
| — |
| — | |
02/01/22 to 02/28/22 |
| — |
| — |
| — |
| — | |
03/01/22 to 03/31/22 |
| 2,831 |
| 33.85 |
| — |
| — | |
Total |
| 3,941 | $ | 34.70 |
| — |
| — | |
| (1) | As permitted under the Company’s equity compensation plan, these shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of stock. Shares withheld for tax withholding obligations do not affect the total number of shares available for repurchase under any approved common stock repurchase plan. At March 31, 2022, the Company did not have an authorized stock repurchase plan in place. |
Item 6. Other Information
None.
Item 7. Exhibits
(a) | Exhibits | ||
31.1 | |||
31.2 | |||
32.1 | |||
32.2 | |||
101.1 SCH | Inline XBRL Taxonomy Extension Schema Document (filed herewith). | ||
101.2 CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith). | ||
101.3 DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (filed herewith). | ||
101.4 LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (filed herewith). | ||
101.5 PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith). | ||
104 | Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in exhibits 101.*) (filed herewith). | ||
* Denotes management contract or compensatory plan or arrangement. | |||
26
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DATE: | May 4, 2022 | ALLIED MOTION TECHNOLOGIES INC. | |
|
| By: | /s/ Michael R. Leach |
|
| Michael R. Leach | |
|
| Senior Vice President & Chief Financial Officer | |
27
EXHIBIT 31.1
CERTIFICATION
I, Richard S. Warzala, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Allied Motion Technologies Inc. (the “registrant”); |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
| 5. | I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s other verifying officer, the auditors and the audit committee of registrant’s Board of Directors (or persons performing the equivalent functions): |
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
Date: May 4, 2022 | /s/ Richard S. Warzala |
| Richard S. Warzala |
| Chief Executive Officer |
EXHIBIT 31.2
CERTIFICATION
I, Michael R. Leach, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Allied Motion Technologies Inc. (the “registrant”); |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
| 5. | I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s other certifying officer, the auditors and the audit committee of registrant’s Board of Directors (or persons performing the equivalent functions): |
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
Date: May 4, 2022 | /s/ Michael R. Leach |
| Michael R. Leach |
| Chief Financial Officer |
EXHIBIT 32.1
Certification of Periodic Financial Reports
Pursuant to 18 U.S.C. Section 1350
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Allied Motion Technologies Inc. (the “Company”) certifies to his knowledge that:
| (1) | The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2022 fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 4, 2022 | /s/ Richard S. Warzala |
| Richard S. Warzala |
| Chief Executive Officer |
EXHIBIT 32.2
Certification of Periodic Financial Reports
Pursuant to 18 U.S.C. Section 1350
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Allied Motion Technologies Inc. (the “Company”) certifies to his knowledge that:
| (1) | The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2022 fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 4, 2022 | /s/ Michael R. Leach |
| Michael R. Leach |
| Chief Financial Officer |